title: Plasminogen activator inhibitor-1: a novel therapeutic target for hypertension?
authors.affiliation: Department of Medicine, Harrington Heart and Vascular Institute, University Hospitals Case Medical Center, Case Western Reserve University School of Medicine, Cleveland, OH (D.I.S.); and Division of Nephrology and Hypertension, North Shore University Health System, Evanston, IL (N.M.S.).
authors.forename: Daniel I
authors.initials: DI
authors.lastname: Simon
authors.forename: Norman M
authors.initials: NM
authors.lastname: Simon
mesh_terms: D000818:Animals; D016922:Cellular Senescence / Q000187:drug effects*; D005260:Female; D006973:Hypertension / Q000139:chemically induced* / Q000188:drug therapy*; D008297:Male; D019331:NG-Nitroarginine Methyl Ester / Q000494:pharmacology*; D058258:Serpin E2 / Q000037:antagonists & inhibitors*
chemical_list: D058258:Serpin E2; C511869:Serpine2 protein, mouse; D019331:NG-Nitroarginine Methyl Ester
keywords: Editorials; arteriosclerosis; hypertension; plasminogen activator inhibitor 1; plasminogen activators; protease inhibitors